Runge MS - Search Results

1

Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons.

Runge MS, Harker LA, Bode C, Ruef J, Kelly AB, Marzec UM, Allen E, Caban R, Shaw SY, Haber E, Hanson SR. Runge MS, et al. Circulation. 1996 Sep 15;94(6):1412-22. doi: 10.1161/01.cir.94.6.1412. Circulation. 1996. PMID: 8823001

2

Hybrid molecules: insights into plasminogen activator function.

Runge MS, Bode C, Haber E, Quertermous T. Runge MS, et al. Mol Biol Med. 1991 Apr;8(2):245-55. Mol Biol Med. 1991. PMID: 1806766 Review.

3

A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.

Runge MS, Quertermous T, Zavodny PJ, Love TW, Bode C, Freitag M, Shaw SY, Huang PL, Chou CC, Mullins D, et al. Runge MS, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10337-41. doi: 10.1073/pnas.88.22.10337. Proc Natl Acad Sci U S A. 1991. PMID: 1946453 Free PMC article.

4

Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.

Bode C, Runge MS, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E. Bode C, et al. Among authors: runge ms. Circulation. 1990 Jun;81(6):1974-80. doi: 10.1161/01.cir.81.6.1974. Circulation. 1990. PMID: 2111744

5

Future directions in plasminogen activator therapy.

Bode C, Runge MS, Haber E. Bode C, et al. Among authors: runge ms. Clin Cardiol. 1990 Jun;13(6):375-81. doi: 10.1002/clc.4960130602. Clin Cardiol. 1990. PMID: 2188764 Free article. Review.

6

Antibody-targeted thrombolytic agents.

Haber E, Quertermous T, Matsueda GR, Runge MS, Bode C. Haber E, et al. Among authors: runge ms. Jpn Circ J. 1990 Apr;54(4):345-53. doi: 10.1253/jcj.54.345. Jpn Circ J. 1990. PMID: 2204740 Review.

7

The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.

Lubin IM, Caban R, Runge MS. Lubin IM, et al. Among authors: runge ms. J Biol Chem. 1993 Mar 15;268(8):5550-6. J Biol Chem. 1993. PMID: 8449917 Free article.

8

The promise of new genetically engineered plasminogen activators.

Cutler D, Bode C, Runge MS. Cutler D, et al. Among authors: runge ms. J Vasc Interv Radiol. 1995 Nov-Dec;6(6 Pt 2 Suppl):3S-7S. doi: 10.1016/s1051-0443(95)71241-6. J Vasc Interv Radiol. 1995. PMID: 8770835 Review.

9

Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting.

Bode C, Hanson SR, Schmedtje JF Jr, Haber E, Mehwald P, Kelly AB, Harker LA, Runge MS. Bode C, et al. Among authors: runge ms. Circulation. 1997 Feb 18;95(4):800-4. doi: 10.1161/01.cir.95.4.800. Circulation. 1997. PMID: 9054733

10

Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis.

Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, Patterson C. Ruef J, et al. Among authors: runge ms. Circ Res. 1997 Jul;81(1):24-33. doi: 10.1161/01.res.81.1.24. Circ Res. 1997. PMID: 9201024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters